Ding Xia 4

What Happened
Ding Xia, a director of USANA Health Sciences (USNA), was granted 6,527 restricted stock units (RSUs) on May 7, 2026. The award is recorded as a derivative acquisition at $0.00 (no cash purchase). Each RSU is a contingent right to one share of USNA common stock; actual shares will be delivered only if and when the RSUs vest.

Key Details

• Transaction date: May 7, 2026; Grant/Award of 6,527 RSUs at $0.00 (derivative).
• Filing date: Form 4 filed May 11, 2026 (four days after the grant).
• Vesting schedule (footnote): 25% vests on each of July 23, 2026; October 22, 2026; January 21, 2027; and April 22, 2027.
• Footnote: Each RSU represents a contingent right to receive one share upon vesting.
• Shares owned following the transaction were not provided in the supplied details.

Context
This was an equity award (grant), not an open-market purchase or sale. Grants to directors are common and generally compensate service; they do not by themselves indicate buying or selling sentiment. The economic value of the award will depend on USNA’s share price at each vesting date.